Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

3.25p
   
  • Change Today:
      0.35p
  • 52 Week High: 4.25
  • 52 Week Low: 2.90
  • Currency: UK Pounds
  • Shares Issued: 356.04m
  • Volume: 1,648,808
  • Market Cap: 11.57m
  • RiskGrade: 500
2015-12-23 - Suspension of Listing

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E 1.7 n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 5.4  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

HEMO Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
28-Feb-15 n/a (0.01) (0.40)p n/a n/a n/a n/a 0.0%
31-Dec-15 n/a 0.08 0.60p 6.3 n/a n/a n/a 0.0%
31-Dec-16 n/a (0.47) (0.70)p n/a n/a n/a n/a 0.0%
31-Dec-17 n/a (2.36) 1.90p 1.3 n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

HEMO Company Announcements

Result of AGM 27-Jun-2018 11:39 RNS
Posting of Annual Report & Notice of AGM 05-Jun-2018 18:05 RNS
Final Results 30-Apr-2018 16:23 RNS

Latest HEMO Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

HEMO Market Data

Currency UK Pounds
Share Price 3.25p
Change Today 0.35p
% Change 12.07 %
52 Week High 4.25
52 Week Low 2.90
Volume 1,648,808
Shares Issued 356.04m
Market Cap 11.57m
RiskGrade 500

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
24.56% above the market average24.56% above the market average24.56% above the market average24.56% above the market average24.56% above the market average
20.63% above the sector average20.63% above the sector average20.63% above the sector average20.63% above the sector average20.63% above the sector average
Value
24.56% above the market average24.56% above the market average24.56% above the market average24.56% above the market average24.56% above the market average
20.63% above the sector average20.63% above the sector average20.63% above the sector average20.63% above the sector average20.63% above the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 13-Jul-2018

Time Volume / Share Price
16:27 200,000 @ 3.20p
15:55 88,400 @ 3.37p
15:01 73,530 @ 3.38p
14:07 100,000 @ 3.40p
14:04 6,742 @ 3.40p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.
Finance Director Timothy le Druillenec

Top of Page